Core Laboratories Inc. CLB
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- -33.62%
- 1 year
- -33.33%
- Open
- 10.36
- Prev close
- 10.40
- Mkt cap
- 488.21M
- Vol
- 880.17K
- Avg vol
- 595.28K
- EPS
- 0.34
- P/E
- 31.29
- Div yield
- 0.24%
More statistics
- Low
- 10.22
- High
- 10.79
- Forward P/E
- 17.18
- Beta
- 2.36
- Short ratio
- 23.15
- Inst. own
- 112.62%
- Dividend
- 0.04
- Ex-div date
- Nov 3, 2024
- Earnings
- Jan 29, 2025
- 50-d avg
- 19.56
- 200-d avg
- 18.90
- 1y target
- 19.33
News
1 day ago marketbeat.com
Core Laboratories Q3 Earnings Call Highlights
Core Laboratories NYSE: CLB reported higher third-quarter revenue, operating income and earnings per share from the prior quarter, while geopolitical disruptions in the Middle East and Russia-Ukraine…
2 days ago seekingalpha.com
Core Laboratories Inc. (CLB) Q3 2026 Earnings Call Transcript
Core Laboratories Inc. ( CLB ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants Lawrence Bruno - Chairman of the Board, CEO, President & COO Gwendolyn Schreffler - Senior Vice…
3 days ago zacks.com
Core Laboratories (CLB) Q3 Earnings Miss Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.22 per share a year ago.
3 days ago prnewswire.com
CORE LAB REPORTS THIRD QUARTER 2026 RESULTS:
REVENUE OF $ 132.1 MILLION, UP 6% SEQUENTIALLY AND DOWN 2% YEAR-OVER-YEAR OPERATING INCOME OF $ 12.1 MILLION; EX-ITEMS, $12.6 MILLION, UP 35% SEQUENTIALLY AND DOWN 24% YEAR-OVER-YEAR GAAP EARNINGS…
-
3 days ago benzinga.com
Core Laboratories Q3 Adj. EPS $0.16, Inline, Sales $132.077M Miss $132.143M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 27.27 percent decrease over earnings of $0.22 per share from the same…
-
3 days ago benzinga.com
Core Laboratories Sees Q4 GAAP EPS $0.12-$0.20 vs $0.17 Est; Sees Sales $128.500M-$134.500M vs $133.317M Est
Core Laboratories (NYSE:CLB) is looking for Q4 GAAP EPS of $0.12-$0.20 vs $0.17 analyst estimate. sees sales of $128.500 million-$134.500 million vs $133.317 million analyst estimate.